Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: for whom and how

HIGHLIGHTS

• who: Marie Muthspiel from the University of Messina, Italy have published the research work: Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how, in the Journal: (JOURNAL)
• what: In this review, the authors focus on the current knowledge of short DAPT followed by early P2Y12 -inhibitor monotherapy and on DAPT de-escalation from potent P2Y12 -inhibitors to clopidogrel in terms of a personalized medicine .

SUMMARY

European Society of Cardiology (ESC) guidelines recommend a combination of aspirin with ticagrelor or with prasugrel for . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.